Data / Form D filings / CURE PHARMACEUTICAL Corp
CURE PHARMACEUTICAL Corp: Form D filings
CURE PHARMACEUTICAL Corp, a pharmaceuticals company in Oxnard, CA, filed 8 Form D notices with the SEC between 2012 and 2016. The latest, on October 31, 2016, reports $6 million sold of a $6 million offering to 42 investors.
Find out what CURE PHARMACEUTICAL Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1620 BEACON PLACE, Oxnard, CA, 93033
- Phone
- (805) 824-0410
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1554289
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 31, 2016 | New notice | $6,033,963 | $6,033,963 | $0 | 42 | Nov 10, 2015 | sec.gov |
| Oct 31, 2016 | Amendment | $2,000,000 | $2,000,000 | $0 | 1 | Jul 25, 2011 | sec.gov |
| Oct 31, 2016 | New notice | $323,212 | $323,212 | $0 | 1 | Dec 31, 2015 | sec.gov |
| Oct 31, 2016 | New notice | $250,000 | $250,000 | $0 | 1 | Jul 24, 2015 | sec.gov |
| Oct 28, 2016 | New notice | $80,000 | $80,000 | $0 | 1 | Jun 17, 2015 | sec.gov |
| Oct 28, 2016 | New notice | $1,500,000 | $1,500,000 | $0 | 1 | Jul 25, 2011 | sec.gov |
| Mar 25, 2013 | New notice | Indefinite | $300,000 | Indefinite | 1 | Feb 28, 2013 | sec.gov |
| Jul 18, 2012 | New notice | $958,568 | $958,568 | $0 | 12 | Jul 10, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Edward Maliski | Director | |
| Rob Davidson | Executive Officer, Director | |
| Wayne Nasby | Director | |
| Ian Sephton | Director | |
| Vic Branstetter | Director | |
| Mark Udell | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Oct 31, 2016 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CURE PHARMACEUTICAL Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.